IRCCS Istituti Clinici Maugeri

Pavia 27100

0 studies enrolling now · 1 studies all time

What they study most

Focal Segmental Glomerulosclerosis

Studies at this site

• Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis — Completed